Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-19-000821
Filing Date
2019-02-14
Accepted
2019-02-14 16:06:59
Documents
1
Group Members
ROBERTO MIGNONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT bridger-drna123118a1.htm SC 13G/A 71898
  Complete submission text file 0001172661-19-000821.txt   73481
Mailing Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016
Business Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016 212-918-0820
BRIDGER MANAGEMENT, LLC (Filed by) CIK: 0001166309 (see all company filings)

EIN.: 582553507 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87866 | Film No.: 19606148
SIC: 2834 Pharmaceutical Preparations